Only 6% of eligible Americans are getting the lung cancer screening their doctors should already be recommending. Six percent. I have spent years looking at preventive health data, and that number still stops me cold every time I see it.
The statistic comes from a 2022 analysis published in JAMA Oncology, which found that despite updated U.S. Preventive Services Task Force (USPSTF) guidelines expanding eligibility for low-dose CT (LDCT) lung screening, the vast majority of qualifying adults have never had the scan. We are not talking about a rare, expensive, or painful procedure. We are talking about a 10-minute, low-radiation scan that costs roughly $300 and, when used correctly, reduces lung cancer mortality by up to 20%, according to the landmark National Lung Screening Trial. And still, 94 out of every 100 people who qualify walk out of annual physicals without a single mention of it.
That is not a footnote. That is a failure.
Why Pulmonologists Are Pushing Back
For years, lung cancer screening existed in a kind of clinical limbo. Guidelines were narrow, reimbursement was inconsistent, and many primary care physicians simply were not trained to identify the right candidates. Research shows the gap between guideline publication and actual clinical practice in preventive care averages seven to ten years, according to a 2013 paper in the Journal of General Internal Medicine that, frustratingly, still gets cited today because the problem has not gone away.
What changed is the 2021 USPSTF update. The revised criteria lowered the starting age for screening from 55 to 50 and reduced the smoking history threshold from 30 pack-years to 20 pack-years. (A pack-year is one pack per day for one year, so 20 pack-years could mean one pack daily for 20 years, or two packs daily for 10.) That single update added an estimated 6.4 million more Americans to the eligible pool, with disproportionate benefit to Black adults and women, who were systematically excluded under the older, narrower criteria.
Pulmonologists are not just recommending early scans for their own patients now. Many are actively pushing primary care networks to adopt standing screening protocols, because the filter between patient and scan is often a front-desk scheduler who has never heard of a shared decision-making visit.
Did You Know: Under the ACA, LDCT lung screening is covered at zero cost-sharing for eligible patients, meaning no copay and no deductible, when ordered through a qualified shared decision-making visit. Many patients pay out of pocket simply because the visit is coded incorrectly.
Who Actually Qualifies — and Who Is Being Missed
The current USPSTF criteria are specific. You qualify for annual LDCT screening if you are between 50 and 80 years old, currently smoke or quit within the past 15 years, and have a 20 pack-year smoking history. That is it. No symptoms required. No family history required. No prior diagnosis required.
And yet ask yourself honestly: when did you last think seriously about whether you or someone you love meets those criteria?
The patients most commonly missed are not heavy, lifelong smokers. They are people who smoked moderately through their twenties and thirties, quit a decade ago, and now consider themselves done with that chapter of their lives. Their doctors often agree. The chart says “former smoker.” The physical looks clean. Nobody mentions the USPSTF calculator.
Maria, a 54-year-old former smoker in Ohio, had passed three consecutive annual physicals without a single mention of lung screening eligibility. She had quit smoking 11 years earlier, felt healthy, and assumed her doctor would flag anything worth flagging. When she finally read about the USPSTF criteria online and asked about it herself, her LDCT came back showing a Stage I nodule in her right lower lobe. She had surgery six weeks later. Her surgeon told her that if that nodule had been caught at Stage III, the conversation would have been entirely different. Maria found the information herself. Her doctors did not bring it up once.
In my years of research, the pattern I kept seeing was this: the patients who benefit most from early screening are exactly the patients least likely to self-advocate, because they feel well and trust that silence from their doctor means safety.
Warning: A clean annual physical does not rule out early-stage lung cancer. Standard physicals do not include chest imaging. A stethoscope cannot detect a 6mm nodule. The only way to find early lung disease before symptoms appear is through LDCT screening. Feeling fine is not a screening strategy.
The 5-Step Protocol Pulmonologists Now Recommend
If you or someone you care about might qualify, here is the exact sequence that pulmonologists and thoracic oncologists now recommend for moving from curiosity to actual scan.
Step 1: Check your eligibility before your next appointment. Use the American Lung Association’s online eligibility tool at lung.org. It takes under two minutes. You enter your age, smoking history, and quit date (if applicable), and it tells you whether you meet USPSTF criteria. Do this before you call anyone.
Step 2: Request a shared decision-making visit, not a referral. This is the single most important phrase in this article. When you call your primary care physician’s office, say these exact words: “I’d like to schedule a shared decision-making visit to discuss LDCT lung cancer screening.” That phrase triggers the correct billing code (CPT 99406 or the shared decision-making add-on) that qualifies your subsequent scan for zero-cost-sharing under the ACA. “I want a referral for a lung scan” does not do the same thing. The scheduler needs to hear the right words.
Pro Tip: Before your shared decision-making visit, write down your smoking history in exact terms: the years you smoked, the average number of packs per day, and the date you quit if applicable. Bring that written list to the appointment. Shared decision-making visits are typically 15 to 20 minutes, and memory gaps about pack-year history are one of the most common reasons these appointments run off track or result in incomplete documentation that delays your screening order.
Step 3: Confirm the facility uses Lung-RADS scoring. Lung-RADS is the standardized radiological reporting system developed by the American College of Radiology specifically for lung cancer screening. Not all imaging centers use it. When you book your scan, ask directly: “Does your facility report LDCT results using the Lung-RADS classification system?” If the answer is no or uncertain, find a facility that does. Lung-RADS scores (1 through 4) give you and your doctor a consistent, evidence-based framework for understanding your results and deciding on follow-up intervals.
Step 4: Ask for your Lung-RADS score in writing. When your results come in, request the full radiology report, not just a summary call from a nurse. Your report should include your Lung-RADS category, the size and location of any nodules identified, and the recommended follow-up timeline. A Lung-RADS 1 or 2 means no significant findings and annual re-screening. A Lung-RADS 3 or 4 means follow-up imaging or additional workup is needed. You are entitled to this information in plain language, and a good pulmonologist will walk you through it.
Step 5: Keep the annual rhythm. One scan is not screening. The clinical value of LDCT comes from serial imaging, meaning year-over-year comparison that lets radiologists track whether anything is growing, stable, or resolving. The National Lung Screening Trial’s mortality benefit was built on annual scans over multiple years. Missing a year is not a minor gap; it breaks the comparative baseline your doctors rely on. Set a recurring calendar reminder the same week every year. Treat it like a mammogram or colonoscopy. It is exactly that important.
Your Next 3 Steps
The science is actually fascinating here, but science does not save lives. Action does. Here is what to do, starting now.
Today: Go to lung.org and use the Lung Cancer Screening Eligibility Calculator. It takes less than two minutes. If you qualify, screenshot or print your result before you close the tab. If you are not sure whether a family member qualifies, run their numbers too.
This week, before Friday: Call your primary care physician’s office and use this exact phrase when the scheduler answers: “I need to schedule a shared decision-making visit to discuss LDCT lung cancer screening.” Do not say “I want a lung scan.” Do not say “Can you refer me to a pulmonologist.” The specific phrase is what triggers the correct billing code and protects you from a surprise copay. If your doctor’s office pushes back or seems unfamiliar with the process, ask to speak with the nurse or care coordinator directly.
This month: When your scan is booked or completed, confirm in writing that the imaging facility uses Lung-RADS reporting, and request a copy of the full radiology report after your results are in. File it somewhere you will find it next year. The comparison between this year’s scan and next year’s is where the real clinical value lives.
You are not alone in this. The 94% who have not been screened are not careless people. Most of them have never been told they qualify. Now you know. That changes what comes next.
What most doctors do not tell you is that the gap between eligibility and screening is almost never about the patient. It is about the system. And unlike most systemic problems, this one has a workaround you can execute with a single phone call.
Struggling with health decisions that feel overwhelming? The mental load of navigating medical systems can be just as exhausting as the conditions themselves. The Video Call Myth Therapists Are Calling Out is worth reading if you’ve been relying on telehealth to manage anxiety around health concerns — there are real limitations the research is finally surfacing.
